Cidara Therapeutics, Inc. Annual Operating Margin in % from 2022 to 2023

Taxonomy & unit
ratio: %
Description
The operating margin measures the profit a company makes on a dollar of sales after accounting for the direct costs involved in earning those revenues.
Summary
Cidara Therapeutics, Inc. quarterly/annual Operating Margin history and growth rate from 2022 to 2023.
  • Cidara Therapeutics, Inc. Operating Margin for the quarter ending September 30, 2024 was -434 %, a 903% decline year-over-year.
  • Cidara Therapeutics, Inc. annual Operating Margin for 2023 was -38.3 %, a 26.3% increase from 2022.
Operating Margin, Annual (%)
Operating Margin, YoY Annual Growth (%)
Period Value YoY Chg Change % Start Date End Date
2023 -38.3 +13.7 +26.3% Jan 1, 2023 Dec 31, 2023
2022 -52 Jan 1, 2022 Dec 31, 2022
* An asterisk sign (*) next to the value indicates that the value is likely invalid.